Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Bitcoin Well (V.BTCW) Reports Q1 2024 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(33)
•••
Comment by Biofinderon May 23, 2018 7:07pm
168 Views
Post# 28072308

RE:RE:Did You Notice CC Abbott’s “Disclosures”?

RE:RE:Did You Notice CC Abbott’s “Disclosures”?
ilikethebible80 wrote:
Biofinder wrote: She/they no longer currently own any PLI shares. She/they must have sold all their PLI shares after the Ryplazim debacle.

Disclosure: I am/we are long AST, GWPH.

Additional disclosure: I/we have no positions in any stocks mentioned, but may initiate a long position in PFSCF within the next 6 months.
 

Biofinder, your presumption is not correct.  I did not own any PLI shares at the time of the annouced delay.

Best regards,
CC Abbott 

So you pump PLI in an article saying PLI is still a buy, then you dump your shares prior to the (FDA) Ryplazim delay announcement. Interesting. Good to know. Best regards back at ya.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities